thymoquinone has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschner, M; Farkhondeh, T; Kohandel, Z; Samarghandian, S | 1 |
| Ahmad, A; Alkharfy, KM; Raish, M | 1 |
| Hosseinzadeh, H; Razavi, BM | 1 |
| Heuberger, AL; Kester, AC; Reddivari, L; Vanamala, J | 1 |
4 review(s) available for thymoquinone and Cardiovascular Diseases
| Article | Year |
|---|---|
Anti-inflammatory effects of thymoquinone and its protective effects against several diseases.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Cardiovascular Diseases; Cytoprotection; Humans; Inflammation Mediators; Metabolic Diseases | 2021 |
The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19.
Topics: Animals; Antiviral Agents; Benzoquinones; Cardiotonic Agents; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2 | 2021 |
A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome.
Topics: Animals; Benzoquinones; Cardiovascular Diseases; Humans; Hypoglycemic Agents; Metabolic Syndrome; Nigella sativa; Plant Extracts; Treatment Outcome | 2014 |
Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone.
Topics: Antioxidants; Benzoquinones; Cardiovascular Diseases; Chemoradiotherapy, Adjuvant; Humans; Insulin Resistance; Neoplasms; Nigella sativa; Obesity; Plant Extracts; Weight Loss | 2012 |